Toward a better understanding of the mechanistic involvement of GAS5 in trastuzumab-resistant breast cancer cells, they found that knockdown of GAS5 led to cell proliferation and tumor growth in SKBR-3 trastuzumab-resistant cancer cells. Here, GAS5 is linked to neoplasm.